When I see the names of Andy Skibo and Jim Breen, two of ISPE’s guiding beacons, on the same list, I feel humbled as well as honored with this recognition.
Bethesda, Maryland (PRWEB) May 10, 2017
The International Society for Pharmaceutical Engineering (ISPE) announced that CEO and President John Bournas was recognized as a top-10 Industry Influencer on The Medicine Maker’s 2017 Power List. The UK publication’s Power List celebrates 100 individuals “involved in bettering the pharma industry and bringing life-changing medicines to market” across four categories.
Bournas ranked seventh in the "Industry Influencers" segment. He was recognized for developing ISPE’s global initiatives and business operations, leading organizational efforts in solidifying working relationships with international regulators, and spearheading global initiatives such as the Drug Shortages Prevention Plan. Seven ISPE members were recognized on the 2017 Power List overall, including Andy Skibo, former ISPE Board Chair, and Jim Breen, ISPE Board Secretary.
“When I see the names of Andy Skibo and Jim Breen, two of ISPE’s guiding beacons, on the same list, I feel humbled as well as honored with this recognition,” said John Bournas, ISPE CEO and President.
The Medicine Maker Power List recognizes 100 pharmaceutical professionals across four categories, each made up of 25 noteworthy professionals—and each with its own top ten:
- Masters of the Bench – scientists and researchers whose late-night lab work lays the foundations for new therapeutics.
- Industry influencers – individuals who drive industry best practices and regulations, as well as new manufacturing techniques and technologies.
- Business Captains – leaders and entrepreneurs who turn scientific ideas into marketable medicines.
- Champions of Change – patrons of the industry who are striving to make the world a better place by getting medicines to those who need them the most.
View the complete 2017 Power List at http://www.themedicinemaker.com/power-list/2017.
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical life cycle. The more than 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA, and an operations and training center in Tampa, Florida, USA. Visit http://www.ISPE.org for more information.
For more information, contact:
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)